These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 35611989)
1. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma. Chen PT; Hsieh CC; Chen MF Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989 [TBL] [Abstract][Full Text] [Related]
2. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling. Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337 [TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-6 in the radiation response of liver tumors. Chen MF; Hsieh CC; Chen WC; Lai CH Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e621-30. PubMed ID: 22975618 [TBL] [Abstract][Full Text] [Related]
4. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma. Chen MF; Chen PT; Hsieh CC; Wang CC Cells; 2023 Jan; 12(2):. PubMed ID: 36672266 [TBL] [Abstract][Full Text] [Related]
5. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
6. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling. Wu CT; Huang YC; Chen WC; Chen MF Front Oncol; 2021; 11():619365. PubMed ID: 34109109 [TBL] [Abstract][Full Text] [Related]
7. 1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Guo J; Ma Z; Ma Q; Wu Z; Fan P; Zhou X; Chen L; Zhou S; Goltzman D; Miao D; Wu E Curr Med Chem; 2013; 20(33):4131-41. PubMed ID: 23992309 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment. Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040 [TBL] [Abstract][Full Text] [Related]
9. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma. Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058 [No Abstract] [Full Text] [Related]
10. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling. Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116 [TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
12. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149 [TBL] [Abstract][Full Text] [Related]
13. The role of IL-6 in the radiation response of prostate cancer. Wu CT; Chen MF; Chen WC; Hsieh CC Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095 [TBL] [Abstract][Full Text] [Related]
14. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model. Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166 [TBL] [Abstract][Full Text] [Related]
15. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475 [TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma. Huang Y; Sheng H; Xiao Y; Hu W; Zhang Z; Chen Y; Zhu Z; Wu D; Cao C; Sun J Radiother Oncol; 2021 Sep; 162():34-44. PubMed ID: 34214613 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of (-)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Choi C; Cho Y; Son A; Shin SW; Lee YJ; Park HC Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 33003597 [TBL] [Abstract][Full Text] [Related]
18. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment. Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243 [TBL] [Abstract][Full Text] [Related]
19. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3. Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751 [TBL] [Abstract][Full Text] [Related]
20. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Gu FM; Li QL; Gao Q; Jiang JH; Zhu K; Huang XY; Pan JF; Yan J; Hu JH; Wang Z; Dai Z; Fan J; Zhou J Mol Cancer; 2011 Dec; 10():150. PubMed ID: 22171994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]